144 related articles for article (PubMed ID: 35439348)
1. Does low-intensity pulsed ultrasound enhance repigmentation in vitiligo?
Sindhuja T; Chandra AD; Pathak M; Gupta V
Dermatol Ther; 2022 Jul; 35(7):e15523. PubMed ID: 35439348
[No Abstract] [Full Text] [Related]
2. What is successful repigmentation in vitiligo from the point of view of patients?
Narayan VS; Uitentuis SE; Bekkenk MW; Wolkerstorfer A
Br J Dermatol; 2021 Jan; 184(1):165-166. PubMed ID: 32726875
[No Abstract] [Full Text] [Related]
3. Efficacy of 308-nm excimer laser treatment for refractory vitiligo: a case series of treatment based on the minimal blistering dose.
Noborio R; Nomura Y; Nakamura M; Nishida E; Kiyohara T; Tanizaki H; Morita A
J Eur Acad Dermatol Venereol; 2021 Apr; 35(4):e287-e289. PubMed ID: 33232541
[No Abstract] [Full Text] [Related]
4. Mechanisms of repigmentation induced by photobiomodulation therapy in vitiligo.
Yu S; Lan CE; Yu HS
Exp Dermatol; 2019 Feb; 28 Suppl 1():10-14. PubMed ID: 30698884
[TBL] [Abstract][Full Text] [Related]
5. The additive efficacy of therapeutic low-intensity pulsed ultrasound in the treatment of vitiligo: A randomized, left-right comparison clinical trial.
Liao YH; Chen WS; Jee SH
Dermatol Ther; 2021 Jan; 34(1):e14648. PubMed ID: 33296553
[TBL] [Abstract][Full Text] [Related]
6. Repigmentation of poliosis in a patient with segmental vitiligo.
Bae JM; Kwon HS; Lee JH; Kim GM
J Am Acad Dermatol; 2016 Jul; 75(1):e23-4. PubMed ID: 27317537
[No Abstract] [Full Text] [Related]
7. Repigmentation by outer-root-sheath-derived melanocytes: proof of concept in vitiligo and leucoderma.
Vanscheidt W; Hunziker T
Dermatology; 2009; 218(4):342-3. PubMed ID: 19174603
[TBL] [Abstract][Full Text] [Related]
8. Repigmentation in vitiligo: position paper of the Vitiligo Global Issues Consensus Conference.
Gan EY; Eleftheriadou V; Esmat S; Hamzavi I; Passeron T; Böhm M; Anbar T; Goh BK; Lan CE; Lui H; Ramam M; Raboobee N; Katayama I; Suzuki T; Parsad D; Seth V; Lim HW; van Geel N; Mulekar S; Harris J; Wittal R; Benzekri L; Gauthier Y; Kumarasinghe P; Thng ST; Silva de Castro CC; Abdallah M; Vrijman C; Bekkenk M; Seneschal J; Pandya AG; Ezzedine K; Picardo M; Taïeb A;
Pigment Cell Melanoma Res; 2017 Jan; 30(1):28-40. PubMed ID: 27864868
[TBL] [Abstract][Full Text] [Related]
9. The effect of NB-UVB on noncultured melanocyte and keratinocyte transplantation in treatment of generalized vitiligo using two different donor-to-recipient ratios.
Tawfik YM; Abd Elazim NE; Abdel-Motaleb AA; Mohammed RAA; Tohamy AMA
J Cosmet Dermatol; 2019 Apr; 18(2):638-646. PubMed ID: 30280485
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of 308-nm Monochromatic Excimer Lamp Versus Other Phototherapy Devices for Vitiligo: A Systematic Review with Meta-Analysis.
Lopes C; Trevisani VF; Melnik T
Am J Clin Dermatol; 2016 Feb; 17(1):23-32. PubMed ID: 26520641
[TBL] [Abstract][Full Text] [Related]
11. Correlation of clinical efficacy and psychosocial impact on vitiligo patients by excimer laser treatment.
Al-Shobaili HA
Ann Saudi Med; 2014; 34(2):115-21. PubMed ID: 24894779
[TBL] [Abstract][Full Text] [Related]
12. Determination of skin repigmentation progression.
Nugroho H; Fadzil MH; Yap VV; Norashikin S; Suraiya HH
Annu Int Conf IEEE Eng Med Biol Soc; 2007; 2007():3442-5. PubMed ID: 18002737
[TBL] [Abstract][Full Text] [Related]
13. Monochromatic excimer light versus combination of topical steroid with vitamin D3 analogue in the treatment of nonsegmental vitiligo: a randomized blinded comparative study.
Abdel Latif AA; Ibrahim SM
Dermatol Ther; 2015; 28(6):383-9. PubMed ID: 26358764
[TBL] [Abstract][Full Text] [Related]
14. Treatment outcome and persistence of repigmentation from narrow-band ultraviolet B phototherapy in vitiligo.
Silpa-Archa N; Weerasubpong P; Junsuwan N; Yothachai P; Supapueng O; Wongpraparut C
J Dermatolog Treat; 2019 Nov; 30(7):691-696. PubMed ID: 30474443
[No Abstract] [Full Text] [Related]
15. Preliminary study on the treatment of vitiligo with carbon dioxide fractional laser together with tacrolimus.
Chen W; Zhou Y; Huang FR; Luo D; Wang DG
Lasers Surg Med; 2018 Oct; 50(8):829-836. PubMed ID: 29635693
[TBL] [Abstract][Full Text] [Related]
16. Platelet-rich plasma: Potential role in combined therapy for vitiligo.
Shih S
Dermatol Ther; 2019 Jan; 32(1):e12773. PubMed ID: 30338878
[No Abstract] [Full Text] [Related]
17. A single-arm open-label clinical trial of autologous epidermal cell transplantation for stable vitiligo: A 30-month follow-up.
Orouji Z; Bajouri A; Ghasemi M; Mohammadi P; Fallah N; Shahbazi A; Rezvani M; Vaezirad F; Khalajasadi Z; Alizadeh A; Taghiabadi E; Dashtbozorgi S; Aghdami R; Hosseini SE; Bahahrvand H; Shafieyan S; Aghdami N
J Dermatol Sci; 2018 Jan; 89(1):52-59. PubMed ID: 29103774
[TBL] [Abstract][Full Text] [Related]
18. International Initiative for Outcomes (INFO) for vitiligo: workshops with patients with vitiligo on repigmentation.
Eleftheriadou V; Hamzavi I; Pandya AG; Grimes P; Harris JE; Huggins RH; Lim HW; Elbuluk N; Bhatia B; Tovar-Garza A; Nahhas AF; Braunberger T; Ezzedine K
Br J Dermatol; 2019 Mar; 180(3):574-579. PubMed ID: 30030843
[TBL] [Abstract][Full Text] [Related]
19. Vitiligo as a skin memory disease: The need for early intervention with immunomodulating agents and a maintenance therapy to target resident memory T cells.
Boniface K; Seneschal J
Exp Dermatol; 2019 Jun; 28(6):656-661. PubMed ID: 30636075
[TBL] [Abstract][Full Text] [Related]
20. Combined treatment with fractional carbon dioxide laser, autologous platelet-rich plasma, and narrow band ultraviolet B for vitiligo in different body sites: A prospective, randomized comparative trial.
Abdelghani R; Ahmed NA; Darwish HM
J Cosmet Dermatol; 2018 Jun; 17(3):365-372. PubMed ID: 28834191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
